ketoconazole has been researched along with Hyperglycemia, Postprandial in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The target sirolimus area under the concentration curve (AUC) of 3,810 ng-h/mL was achieved at sirolimus doses of 90, 16, and 25 mg in the sirolimus alone, sirolimus plus ketoconazole, and sirolimus plus grapefruit juice studies, respectively." | 2.77 | Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients. ( Cohen, EE; Eaton, KN; Fleming, GF; Fox-Kay, K; Gajewski, TF; Hartford, C; House, L; Kocherginsky, M; Maitland, ML; Moshier, K; Nallari, A; Ramirez, J; Ratain, MJ; Undevia, SD; Wu, K; Zha, Y, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, EE | 1 |
| Wu, K | 1 |
| Hartford, C | 1 |
| Kocherginsky, M | 1 |
| Eaton, KN | 1 |
| Zha, Y | 1 |
| Nallari, A | 1 |
| Maitland, ML | 1 |
| Fox-Kay, K | 1 |
| Moshier, K | 1 |
| House, L | 1 |
| Ramirez, J | 1 |
| Undevia, SD | 1 |
| Fleming, GF | 1 |
| Gajewski, TF | 1 |
| Ratain, MJ | 1 |
1 trial available for ketoconazole and Hyperglycemia, Postprandial
| Article | Year |
|---|---|
Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2012 |